In 3,541 people with MGUS found by population screening in Iceland, follow-up vs no notification increased smoldering myeloma detection (8.6% v 0.3%; HR 27.46) over a median 4.5 years, but active malignancy rates did not differ; notification showed no psychological harm.
RCTn = 3,541
Rögnvaldsson et al. Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up